MedPath

HRA Pharma Rare Diseases SAS

🇫🇷France
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.hra-pharma-rare-diseases.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

FDA:2
NMPA:1
CANADA:1

Drug Approvals

Mitotane Tablets

Product Name
米托坦片
Approval Number
国药准字HJ20230105
Approval Date
Sep 5, 2023
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.